Tag Archives: GeneXpert

Xpert use reduced wait for treatment, study shows, but health system, patient challenges remain barriers to full benefits

By on .

The demand for, and the promise of, quick accurate tools to diagnose tuberculosis, and to discover resistance to basic TB treatments, are based on a simple and seemingly irrefutable premise. Such tools, it has been pointed out, make early and effective treatment possible, benefiting both patients and public with faster and more frequent cures, and […]

AIDS 2014: HIV and tuberculosis are one disease in Southern Africa

By on .

Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia through the coming week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA – “We must ensure that the worlds of HIV and TB focus on individual human beings instead of individual diseases” This message headlined remarks from Mark […]

Tuberculosis R&D must be U.S. diplomatic priority, say global health leaders

By on .

Along with maintaining funding for fighting global tuberculosis, the United States government must better coordinate with the most affected countries on TB research and development, said global health leaders Monday at a Center for Strategic and International Studies event in Washington, examining challenges to global tuberculosis efforts. This point, along with the recommendation that the […]

When XDR-TB spread in Mumbai, “lots of togetherness” led to a path of solutions

By on .

In Mumbai, the challenges to controlling the spread of drug-resistant TB are as dense, diverse and sprawling as the place itself. A small dot on the map, it is a “mega city,” as Mumbai TB officer Dr. Minni Khetarpal notes. It is the economic capital of India, the most urbanized region, and an epicenter for […]

TB Reach project results show need for new approaches to lift case detection rates

By on .

For a decade and a half after the World Health Organization launched the expansion of directly observed treatment for tuberculosis, strides against the disease, highlighted by a nearly six-fold increase in cases documented, looked promising, an article released Thursday on PLOS ONE notes. But over the last half decade, with efforts largely reliant on “passive […]

The cost of cutting PEPFAR, What VOICE did tell us, and answers to other pressing questions . . .

By on .

If we want an AIDS-free generation, why are we cutting PEPFAR? The Obama administration’s budget request for fiscal year 2014, which includes a fourth consecutive cut to funding for the President’s Emergency Plan For AIDS Relief that would bring the program to its lowest funding level since 2007, raises questions, this piece by amfAR public […]

Wrapping up CROI 2013, Part I: TB on the verge, VOICE trial point to future research needs, sequestration consequence points to rough road ahead

By on .

Science Speaks spent March 3 – 6 at the Conference on Retroviruses and Opportunistic Infections, covering breaking research news and discussions. Today and tomorrow we will wrap up with summaries of sessions, and questions they raised. Today Science Speaks will look at a obstacle for researchers, while presentations pointed to directions for future studies First […]

More than a decade of countering disease and disaster in Haiti penitentiary yields results as donors turn attention to prisons

By on .

The following is the first of a two-part feature on health and justice in a Haitian prison. Today Science Speaks looks at how a decade of work by an organization called Health through Walls has led to recognition of and responses to conditions there, with tools to diagnose tuberculosis among prisoners. When Dr. John May […]